Interferon and nucleotide reverse transcriptase inhibitor

This page covers all Interferon and nucleotide reverse transcriptase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Interferon receptor, reverse transcriptase.

Targets

Interferon receptor, reverse transcriptase

Phase 3 pipeline (1)

• Peginterferon-alfa 2a and tenofovir · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Infectious Diseases
  Peginterferon-alfa 2a is an interferon that modulates the immune system to treat viral infections, while tenofovir is a nucleotide reverse transcriptase inhibitor that blocks viral replication.

Patent intelligence

• interferon and nucleotide reverse transcriptase inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates